Yosuke Suehiro
Hiroshima, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Efficacy and Safety of Second-Line Lenvatinib After First-Line Durvalumab Plus Tremelimumab in Unresectable Hepatocellular Carcinoma.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: October 18, 2025
Correction to: Serum interleukin-6 level predicts the prognosis for patients with alcohol-related acute-on-chronic liver failure.
Journal: Hepatology international
Published: May 27, 2023
Correlation between serum pro-inflammatory cytokine levels and the prognosis of the patients with acute liver failure.
Journal: Journal of gastroenterology and hepatology
Published: March 26, 2023
Serum interleukin-6 level predicts the prognosis for patients with alcohol-related acute-on-chronic liver failure.
Journal: Hepatology international
Published: November 18, 2022
Acute liver injury in a non-alcoholic fatty liver disease patient with chloroform exposure: a case report.
Journal: Clinical journal of gastroenterology
Published: November 16, 2022
HBV with precore and basal core promoter mutations exhibits a high replication phenotype and causes ER stress-mediated cell death in humanized liver chimeric mice.
Journal: Hepatology (Baltimore, Md.)
Published: August 25, 2022
Complete Response for Advanced Hepatocellular Carcinoma by Conversion Surgery Therapy Following a Good Response of Regorafenib Despite Rapid Progressive Disease with Sorafenib.
Journal: Internal medicine (Tokyo, Japan)
Published: July 01, 2021
Hepatitis B Virus (HBV) Upregulates TRAIL-R3 Expression in Hepatocytes Resulting in Escape From Both Cell Apoptosis and Suppression of HBV Replication by TRAIL.
Journal: The Journal of infectious diseases
Published: June 14, 2021
Successful multimodality treatment for advanced hepatocellular carcinoma with tumor thrombosis of the main portal trunk: a case study.
Journal: Clinical journal of gastroenterology
Published: May 14, 2021
Clinical Outcomes of 2nd- and 3rd-Line Regorafenib for Advanced Hepatocellular Carcinoma.
Journal: Oncology
Published: December 29, 2020
Hepatic Arterial Infusion Chemotherapy Combined with Radiation Therapy for Advanced Hepatocellular Carcinoma with Tumor Thrombosis of the Main Trunk or Bilobar of the Portal Vein.
Journal: Liver cancer
Published: August 20, 2020
Last Updated: 09/26/2026